
Publication|Articles|July 1, 2008
July 2008 Oncology News International
Advertisement
Cover Story
Dr. Larry Norton & the Case of the Recurring Mass
Novel Agents May Overcome Resistance to Trastuzumab
DEPARTMENTS
Focus on Breast Cancer
Lapatinib Plus Trastuzumab Extends Progression-Free Survival in Women With HER2-Positive Metastatic Breast Cancer
International News
Bevacizumab Improves PFS in Advanced Breast Cancer
Focus on Lung Cancer
RNA Analysis Can Predict Lung Cancer Among Smokers
Focus on Prostate Cancer
Custirsen, an Antisense Oligonucleotide, May Enhance Docetaxel Efficacy in Hormone-Refractory Prostate Cancer
Vantage Point: Impressive' Pain results; Tolerability Questioned
Focus on Colon Cancer
KRAS Status Predicts Benefit for Cetuximab in Met Colon Ca
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Zanidatamab-Based Regimens for First-Line HER2+ Gastric Cancers
2
FDA Grants Priority Review to Dostarlimab in dMMR/MSI-H Rectal Cancer
3
Lenvatinib Combo Holds Ground Against HER2 ADCs in Endometrial Cancer
4
FDA Grants Fast Track Designation to ERAS-0015 for Pancreatic Adenocarcinoma
5






























































